ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Triplet Combination of Azacitidine, Venetoclax, and Gilteritinib for Pts With FLT3-Mutated AML: Updated Results From a Phase I/II Study
By
ASH 2022 Conference Coverage
FEATURING
Nicholas Short
By
ASH 2022 Conference Coverage
FEATURING
Nicholas Short
501 views
January 5, 2023
Login to view comments.
Click here to Login
Leukemia